Prof. Dr. H. Levent Doğanay

• COVID-19 9 publications
  Source : OpenAlex / PubMed MeSHVoir les publications
• Stéatose hépatique 8 publications
• Tumeurs du sein 5 publications
• Carcinome hépatocellulaire 4 publications
• Tumeurs du foie 4 publications
• Tumeurs colorectales 3 publications
• Infections à Helicobacter 3 publications
• Cirrhose du foie 2 publications
• Tumeurs 2 publications
• Hépatite B 2 publications

Domaines d’intérêt médical indiqués par le médecin lui-même sur sa page du site de l’établissement. Source : livhospital.com.

Expérience

• Expérience2022–2026: VM Pendik Medikal Park Hastanesi – Gastroenteroloji Profesörülivhospital.com
• Expérience2022–Halen: Bahçeşehir Üniversitesi Tıp Fakültesi – İç Hastalıkları ve Gastroenteroloji Profesörülivhospital.com
• Expérience2021–2022: Ümraniye Eğitim ve Araştırma Hastanesi – Gastroenteroloji Profesörülivhospital.com
• Expérience2024–Halen: Hepato Gastroenteroloji Derneği (Hebipa) – Yönetim Kurulu Üyesilivhospital.com
• Expérience2021–2023: Türk Karaciğer Araştırmaları Derneği (TKAD) – Yönetim Kurulu Üyesilivhospital.com
• Expérience2015–2021: Ümraniye Eğitim ve Araştırma Hastanesi – Gastroenteroloji Kliniği Eğitim ve İdari Sorumlusulivhospital.com
• Expérience2014–2022: Ümraniye Eğitim ve Araştırma Hastanesi – Gastroenteroloji Doçentilivhospital.com
• Expérience2011–2014: Ümraniye Eğitim ve Araştırma Hastanesi – Gastroenteroloji Doçentilivhospital.com
• Expérience2015–2022: İstanbul İl Sağlık Müdürlüğü – Genomik Laboratuvar (GLAB) Koordinatörülivhospital.com
• Expérience2014–2021: Northern Clinics of Istanbul Dergisi (WoS ve PubMed’de indekslenir) – Kurucu Editörlivhospital.com
• Expérience2008–2011: Göztepe Eğitim ve Araştırma Hastanesi – Gastroenteroloji Yan Dal Asistanılivhospital.com
• Expérience2007–2007: Nusaybin Devlet Hastanesi – İç Hastalıkları Uzmanılivhospital.com
• Expérience2002–2006: Dokuz Eylül Üniversitesi Tıp Fakültesi – İç Hastalıkları Asistanılivhospital.com

Formation

• Formation1995–2001: Ege Üniversitesi Tıp Fakültesi – Tıp Doktorulivhospital.com
• Formation2002–2006: Dokuz Eylül Üniversitesi – İç Hastalıkları Uzmanlık Eğitimilivhospital.com
• Formation2008–2011: Göztepe Eğitim ve Araştırma Hastanesi – Gastroenteroloji Yan Dal Uzmanlık Eğitimilivhospital.com

• SpécialitéHépato-gastro-entérologielivhospital.comD’après la source
• ÉtablissementLiv Hospital Uluslivhospital.comD’après la source
• Sujet de travailCOVID-19Déduit de 9 publications · Version du modèle —D’après la source
• Publications128 publicationsOpenAlexD’après la source
• Dernière synchronisation4 novembre 2026 21:08https://www.livhospital.com/prof-dr-levent-doganaylivhospital.com

1. Variant reclassification in cancer susceptibility genes and an updated variant spectrum of Turkish breast and colorectal cancer patients

   Human Genomics, 2026

   DOI 10.1186/s40246-026-00915-0 PMID 41656315 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

2. A human pan-disease blood atlas of the circulating proteome

   Science, 2025

   DOI 10.1126/science.adx2678 PMID 41066540 53 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

3. Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients

   Cancer Medicine, 2024

   DOI 10.1002/cam4.6852 PMID 38308423 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

4. The antibody response to COVID-19 among kidney transplant recipients who had PCR confirmed infection

   2024

   DOI 10.22541/au.170666221.16551849/v1 Texte intégral en libre accèsSource : OpenAlex

5. The acute effect of different NAD+ precursors included in the combined metabolic activators

   Free Radical Biology and Medicine, 2023

   DOI 10.1016/j.freeradbiomed.2023.05.032 PMID 37271226 15 citations (Europe PMC) Source : OpenAlex

6. Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators

   Free Radical Biology and Medicine, 2023

   DOI 10.1016/j.freeradbiomed.2023.05.013 PMID 37245532 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

7. Consistency of variant interpretations among bioinformaticians and clinical geneticists in hereditary cancer panels

   European Journal of Human Genetics, 2022

   DOI 10.1038/s41431-022-01060-7 PMID 35132179 9 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

8. Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer

   Expert Review of Molecular Diagnostics, 2022

   DOI 10.1080/14737159.2022.2048373 PMID 35240897 3 citations (Europe PMC) Source : OpenAlex

9. Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family

   Cancer Genetics, 2022

   DOI 10.1016/j.cancergen.2022.10.144 PMID 36368126 3 citations (Europe PMC) Source : OpenAlex

10. A New Risk-Scoring System for Colorectal Cancer and Polyp Screening by Turkish Colorectal Cancer and Polyp Study Group

    The Turkish Journal of Gastroenterology, 2022

    DOI 10.5152/tjg.2022.21072 PMID 35550537 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex